Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 16, Issue 4, 1996, Pages 600-605

  Sakai, Masakazu ^a   Miyazaki, Akira ^a   Hakamata, Hideki ^a   Sato, Yoshihiro ^a   Matsumura, Takeshi ^a   Kobori, Shozo ^a   Shichiri, Motoaki ^a   Horiuchi, Seikoh ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

foam cell; human monocyte derived macrophage; lysophosphatidylcholine; oxidized LDL; scavenger receptor

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE;

ACETYLATION; ANIMAL CELL; ARTICLE; ATHEROGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; DRUG POTENTIATION; GROWTH STIMULATION; HUMAN; HUMAN CELL; MACROPHAGE FUNCTION; MITOGENESIS; MONOCYTE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0029869987     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.16.4.600     Document Type: Article

References (37)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
2. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med. 1989;320:915-924.
3. Palinski W, Rosenfeld ME, Ylä-Herttuala S, Gurtner GC, Socher SS, Butler SW, Parthasarathy S, Carew TE, Steinberg D. Low density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci U S A. 1989;86:1372-1376.
4. Ylä-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
5. Yui S, Sasaki T, Miyazaki A, Horiuchi S, Yamazaki M. Induction of murine macrophage growth by modified LDLs. Arterioscler Thromb. 1993;13:331-337.
6. Sakai M, Miyazaki A, Hakamata H, Sasaki T, Yui S, Yamazaki M, Shichiri M, Horiuchi S. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem. 1994;269:31430-31435.
7. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci U S A. 1990;87:4600-4604.
8. Rosenfeld ME, Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis. 1990;10:680-687.
9. Spagnoli LG, Orlandi A, Santeusanio G. Foam cells of the rabbit atherosclerotic plaque arrested in metaphase by colchicine show a macrophage phenotype. Atherosclerosis. 1991;88:87-92.
10. Von Furth R. Origin and turnover of monocytes and macrophages. Curr Top Pathol. 1989;78:125-150.
11. Takahashi K, Takahashi H, Naito M, Sato T, Kojima M. Ultrastructural and functional development of macrophages in the dermal tissue of rat fetuses. Cell Tissue Res. 1983;232:539-552.
12. Sawter RT, Strauabach PH, Volkman A. Resident macrophage proliferation in mice depleted of blood monocytes by strontium-98. Lab Invest. 1982;46:165-170.
13. Sawter RT. The significance of local resident pulmonary alveolar macrophage proliferation to population renewal. J Leukoc Biol. 1986;39:77-87.
14. Yamada M, Naito M, Takahashi K. Kupffer cell proliferation and glucan-induced granuloma formation in mice depleted of blood monocytes by strontium-89. J Leukoc Biol. 1990;47:195-205.
15. Naito M, Takahashi K. The role of Kupffer cells in glucan-induced granuloma formation in the liver of mice depleted of blood monocytes by administration of strontium-89. Lab Invest. 1991;64:664-674.
16. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate, I: changes that lead to fatty streak formation. Arteriosclerosis. 1984;4:323-340.
17. Faggiotto A, Ross R. Studies of hypercholesterolemia in the nonhuman primate, II: fatty streak conversion to fibrous plaque. Arteriosclerosis. 1984;4:341-356.
18. Hakamata H, Miyazaki A, Sakai M, Suginihara Y, Sakamoto Y-I, Horiuchi S. Species difference in cholesteryl ester cycle and HDL-induced cholesterol efflux from macrophage foam cells. Arterioscler Thromb. 1994;14:1860-1865.
19. Miyazaki A, Sakai M, Suginohara Y, Hakamata H, Sakamoto Y, Morikawa W, Horiuchi S. Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconstituted high density lipoprotein. J Biol Chem. 1994;269:5264-5269.
20. 2+-catalyzed oxidation of human low density lipoprotein. FEBS Lett. 1989;257:435-438.
21. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A. 1987;84:2995-2998.
22. Albers JJ, Tollefson JH, Chen C-H, Steinmetz A. Isolation and characterization of human plasma transfer proteins. Arteriosclerosis. 1984;4:49-58.
23. 2+-mediated oxidation. FEBS Lett. 1992;314:199-202.
24. Miyazaki A, Rahim ATMA, Araki S, Morino Y, Horiuchi S. Chemical cross-linking alters high-density lipoprotein to be recognized by a scavenger receptor in rat peritoneal macrophages. Biochim Biophys Acta, 1991;1082:143-151.
25. Fogelman AM, Haberland ME, Seager J, Hokom M, Edwards PA. Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages. J Lipid Res. 1981;22:1131-1141.
26. Suzaki K, Kobori S, Ide M, Sasahara T, Sakai M, Toyonaga T, Shinihara M, Miyazaki A, Horiuchi S, Takeda H, Shichiri M. Acetyl-low density lipoprotein receptors on rat mesangial cells. Atherosclerosis. 1993;101:177-184.
27. Takayama M, Itoh S, Nagasaki T, Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta. 1977;79:93-98.
28. Kritharides L, Jessup W, Mander EL, Dean RT. Apolipoprotein A-I-mediated efflux of sterols from oxidized LDL-loaded macrophages. Arterioscler Thromb Vasc Biol. 1995;15:276-289.
29. Quinn MT, Parthasarathy S, Steinberg D. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. Proc Natl Acad Sci U S A. 1988;85:2805-2809.
30. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest. 1992;90:1138-1144.
31. Kume N, Gimbrone MA Jr. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest. 1994;93:907-911.
32. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344:160-162.
33. Van Corven EJ, Geoenink A, Jalink K, Eichholtz T, Moolenaar WH. Lysophosphatidate-induced cell proliferation: identification and dissection of signaling pathways mediated by G proteins. Cell. 1989;59:45-54.
34. Van Corven EJ, Van Rijswijk A, Jalink K, Van Der Bend RL, Van Blitterswijk WJ, Moolenaar WH. Mitogcnic action of lysophosphatidic acid and phosphatidic acid on fibroblasts: dependence on acyl-chain length and inhibition by suramin. Biochem J. 1992;281:163-169.
35. Keider S, Brook GJ, Roscnblat M. Fuhrman B, Dankner G, Aviram M. Involvement of the macrophage low-density lipoprotein receptor-binding domains in the uptake of oxidized low-density lipoprotein. Arterioscler Thromb. 1992;12:484-493.
36. Hamilton JA, Dientsman SR. Induction of macrophage DNA synthesis by phorbol esters. J Cell Physiol. 1981;106:445-450.
37. Hamilton JA. Glucocorticoids and prostaglantfins inhibit the induction of macrophage DNA synthesis by macrophage growth factor and phorbol ester. J Cell Physiol. 1983;115:67-74.